FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Garner William J
 2. Date of Event Requiring Statement (Month/Day/Year)
02/11/2013		 3. Issuer Name and Ticker or Trading Symbol
DelMar Pharmaceuticals, Inc. [DMPI]
(Last)
(First)
(Middle)
SUITE 720-999 WEST BROADWAY		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

VANCOUVER, A1 V5Z 1K5		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 0
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Exchangeable Shares   (1)   (1) Common Stock 2,593,541 $ (1) I See Footnote (2)
Warrants 10/03/2011 01/25/2014 Common Stock 50,000 $ 0.96 (3) D  
Options 02/01/2012 02/01/2022 Common Stock 150,000 $ 0.5 (4) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Garner William J
SUITE 720-999 WEST BROADWAY
VANCOUVER, A1 V5Z 1K5		   X      

Signatures

/s/ William J. Garner 02/15/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Exchangeable Shares are shares of Exchangeco (as such terms are defined in the Issuer's Current Report on Form 8-K filed with the SEC on January 31, 2013) which are exchangeable on a 1-for-1 basis at any time for shares of common stock in the Issuer
(2) Shares are held in trust by Jeffrey Bacha.
(3) The warrants are exercisable at $0.96 until 7/25/2013 and thereafter at $1.20 until 1/25/2014.
(4) Actual exercise price is Cdn$0.50. The price disclosed in this Form 3 is the U.S. dollar equivalent as of February 15, 2013, at which time Cdn$0.50 exchanged into USD$0.50.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.